Aegea Medical said this week it raised $17 million in a new financing round and released three-year follow-up data from the pivotal study of its Adaptive Vapor Ablation technology designed for use in endometrial ablation procedures. The funding round was led by Solas BioVentures and its affiliates, with funds slated to support the company’s PACE II […]
Aegea Medical launches post-market Adaptive Vapor Ablation study
Aegea Medical said today that it launched a new post-market study exploring the long-term effects of its Adaptive Vapor Ablation technology in endometrial ablation procedures. The PACE II study will look to enroll up to 50 women who were previously treated in the Menlo Park, Calif.-based company’s pivotal trial of the Adaptive Vapor Ablation tech and […]
Aegea Medical picks up former Cardiokinetix, Concentric Medical CEO Sainz | Personnel Moves – May 14, 2018
Aegea Medical said last week it tapped former Cardiokinetix prez & CEO Maria Sainz as its new president and chief executive officer, effective immediately. Sainz will replace former CEO Don Gurskis, who has held the corner office since 2013. Gurskis will remain on as member of the Redwood City, Calif.-based company’s executive management team. “Maria is […]
Aegea Medical raises $40m
Aegea Medical said today raised a total of $40 million in financing to support the development of its Adaptive Vapor Ablation technology designed for endometrial ablation. The Redwood City, Calif.-based company said the financing included $30 million from Perceptive Advisors and an additional $10 million from existing equity investors including Medtronic (NYSE:MDT), Alloy Ventures, Delphi Ventures, […]
MassDevice Network
@MassDevice
LinkedIn
YouTube